Biodesix's Debt - II Round

Biodesix raised a round of funding on January 10, 2014. Investors include CRG.

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix developed, validated and commercialized VeriStrat, a serum proteo…

Articles about Biodesix's Debt - II Round: